World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
30432
World Ranking
11331
National Ranking
5815

Mei-Jie Zhang publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mei-Jie Zhang sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 397 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mei-Jie Zhang D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mei-Jie Zhang sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mei-Jie Zhang is affiliated with the Medical College of Wisconsin in the United States and specializes in research within the field of medicine. Their work focuses extensively on hematology, with notable contributions in oncology and genetics as well as investigations related to infectious diseases and public health.

The primary topics addressed in Zhang's research include hematopoietic stem cell transplantation, acute myeloid leukemia research, chronic myeloid leukemia treatments, polyomavirus and related diseases, acute lymphoblastic leukemia research, immune cell function and interaction, and chronic lymphocytic leukemia research.

Frequently publishing in scientific journals, Zhang has contributed to several high-impact venues. The most common publication outlets for their work are:

  • Biology of Blood and Marrow Transplantation
  • Blood Advances
  • Bone Marrow Transplantation
  • Blood
  • Leukemia

Some recent papers authored by or involving Mei-Jie Zhang include:

  • "Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia", 2020, JAMA Oncology
  • "Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?", 2020, Blood
  • "Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis", 2020, Biology of Blood and Marrow Transplantation
  • "Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia", 2020, Biology of Blood and Marrow Transplantation
  • "Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR", 2020, Journal of Clinical Oncology

The researcher has collaborated frequently with several coauthors, with whom they have multiple joint publications. These include:

  • Wael Saber
  • Daniel J. Weisdorf
  • Mary Eapen
  • Partow Kebriaei
  • Mary M. Horowitz

Best Publications

  • Outcomes after transplantation of cord Blood or bone marrow from unrelated donors in adults with leukemia

    Mary J. Laughlin;Mary Eapen;Pablo Rubinstein;John E. Wagner

  • Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

    Vanderson Rocha;John E. Wagner;Kathleen A. Sobocinski;John P. Klein

  • Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

    Mary Eapen;Pablo Rubinstein;Mei Jie Zhang;Cladd Stevens

  • IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

    Rowlings Pa;Przepiorka D;Klein Jp;Gale Rp

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation

    Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis

  • Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

    Dao Pei Lu;Lujia Dong;Lujia Dong;Tong Wu;Tong Wu;Xiao Jun Huang;Xiao Jun Huang

  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

    Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  • Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

    Mary Eapen;Vanderson Rocha;Guillermo Sanz;Andromachi Scaradavou

  • Results of Allogeneic Bone Marrow Transplants for Leukemia Using Donors Other Than HLA-Identical Siblings

    R Szydlo;J M Goldman;J P Klein;R P Gale

  • Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

    Jon J. Van Rood;Fausto R. Loberiza;Mei Jie Zhang;Machteld Oudshoorn

  • Alzheimer Disease: evaluation of a functional MR imaging index as a marker.

    Shi-Jiang Li;Zhu Li;Gaohong Wu;Mei-Jie Zhang

  • The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

    Craig Kollman;Stephen R. Spellman;Mei Jie Zhang;Mei Jie Zhang;Anna Hassebroek

  • Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

    Asad Bashey;Mei Jie Zhang;Shannon R. McCurdy;Andrew St Martin

  • Bone marrow transplantation for Fanconi anemia

    E. Gluckman;A. D. Auerbach;M. M. Horowitz;K. A. Sobocinski

  • Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study

    Nelli Bejanyan;Daniel J. Weisdorf;Brent R. Logan;Brent R. Logan;Hai Lin Wang

  • OUTCOME OF TRANSPLANTATION FOR MYELOFIBROSIS

    Karen K. Ballen;Smriti Shrestha;Kathleen A. Sobocinski;Mei Jie Zhang

  • Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.

    J P Klein;J D Rizzo;M J Zhang;N Keiding

  • Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.

    Geoff Hale;Mei-Jie Zhang;Donald Bunjes;H. Grant Prentice

  • Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Editorial comment

    Vanderson Rocha;Eliane Gluckman;Mary Eapen;Pablo Rubinstein

Frequent Co-Authors

Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Parameswaran Hari
Parameswaran Hari Medical College of Wisconsin
John P. Klein
John P. Klein Medical College of Wisconsin
Mark R. Litzow
Mark R. Litzow Mayo Clinic
Marcelo C. Pasquini
Marcelo C. Pasquini Medical College of Wisconsin
Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Marcos de Lima
Marcos de Lima The Ohio State University
Mitchell S. Cairo
Mitchell S. Cairo New York Medical College

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering medicine in the USA opens doors to many healthcare career paths and online learning opportunities. For those interested in advanced research or teaching roles in healthcare, phd in nursing online programs offer flexibility and affordability, letting professionals balance studies with their careers.

RNs aiming to boost qualifications or earnings can explore what is the cheapest rn to bsn program online to find accredited pathways providing excellent value. Students from non-nursing backgrounds looking to transition quickly into nursing should consider direct entry msn online options, which speed up the process of earning a master’s in nursing.

Others who wish to start their healthcare career sooner might explore adn programs—associate degrees in nursing that offer a faster entry into the workforce. Each of these routes presents unique opportunities for specialization and advancement, allowing you to tailor your educational journey and career pathway in healthcare.

Best Scientists Citing Mei-Jie Zhang

Trending Scientists

Recently Published Articles